Literature DB >> 3284385

Mechanism of insulin action on glucose transport in rat skeletal muscle.

E Sternlicht1, R J Barnard, G K Grimditch.   

Abstract

This study was designed to examine the effect of insulin stimulation on glucose transport in rat skeletal muscle. Sarcolemmal vesicles (SL) were isolated from the gastrocnemius-plantaris and quadriceps muscles from insulin-stimulated and control groups. The insulin-stimulated group received an intravenous insulin injection (1 U/kg) 10 min before isolation. The early time course of specific D-glucose transport was linear through 2 s. Michaelis-Menten kinetics at 1.5 s indicated that the Vmax for glucose transport was increased after insulin stimulation compared with controls (4,424 +/- 668 vs. 1,366 +/- 124 pmol.mg protein -1.s-1), whereas the Km remained unchanged (19.4 +/- 0.6 vs. 21.6 +/- 3.1 mM). Scatchard plots for the D-glucose-inhibitable class of cytochalasin B binding sites indicated that insulin stimulation increased the number of binding sites in the SL vesicles (9.3 +/- 0.6 vs. 5.5 +/- 0.3 pmol/mg protein) without altering the Kd (48 +/- 3 vs. 46 +/- 3 nM). That the increase in Vmax was greater than the increase in cytochalasin B binding sites indicates that insulin stimulation caused an increase in the turnover rate of existing transport molecules as well as an increase in the total number of SL glucose transport molecules.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3284385     DOI: 10.1152/ajpendo.1988.254.5.E633

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Insulin stimulation of glucose transport activity in rat skeletal muscle: increase in cell surface GLUT4 as assessed by photolabelling.

Authors:  C M Wilson; S W Cushman
Journal:  Biochem J       Date:  1994-05-01       Impact factor: 3.857

2.  Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity.

Authors:  A D Baron; J S Zhu; J H Zhu; H Weldon; L Maianu; W T Garvey
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

3.  Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.

Authors:  R C Bonadonna; S Del Prato; M P Saccomani; E Bonora; G Gulli; E Ferrannini; D Bier; C Cobelli; R A DeFronzo
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

4.  Glucose regulates its transport in L8 myocytes by modulating cellular trafficking of the transporter GLUT-1.

Authors:  R Greco-Perotto; E Wertheimer; B Jeanrenaud; E Cerasi; S Sasson
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

5.  Cytoskeleton-dependent endocytosis is required for apical type 1 angiotensin II receptor-mediated phospholipase C activation in cultured rat proximal tubule cells.

Authors:  J R Schelling; A S Hanson; R Marzec; S L Linas
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

6.  Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation.

Authors:  P A King; E D Horton; M F Hirshman; E S Horton
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

7.  Evidence for defects in the trafficking and translocation of GLUT4 glucose transporters in skeletal muscle as a cause of human insulin resistance.

Authors:  W T Garvey; L Maianu; J H Zhu; G Brechtel-Hook; P Wallace; A D Baron
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

8.  Adenosine receptors mediate synergistic stimulation of glucose uptake and transport by insulin and by contractions in rat skeletal muscle.

Authors:  L Vergauwen; P Hespel; E A Richter
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

9.  The effects of muscle contraction and insulin on glucose-transporter translocation in rat skeletal muscle.

Authors:  J T Brozinick; G J Etgen; B B Yaspelkis; J L Ivy
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.